Shizukaol B TN5011
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Shizukaol B exerts anti-inflammatory effects in LPS-activated microglia partly by modulating JNK-AP-1 signaling pathway; it also shows significant anti-neuroinflammatory effects by inhibiting nitric-oxide (NO) production in lipopolysaccharide (LPS)-stimul
CAS nr:
142279-40-1
Purity:
98%
Molecular Weight:
732,77
SMILES:
COC(=O)C(\C)=C1\[C@H]2C3=C(C[C@H]4[C@@]5(C)[C@@H]6C[C@@H]6[C@@]6(O)COC(=O)\C(C)=C\COC(=O)CCC(=O)OCC7=C(C[C@H]56)[C@@]24OC7=O)[C@H]2C[C@H]2[C@]3(C)[C@@H](O)C1=O
Formula:
C40H44O13
Pathway:
Immunology/Inflammation,Apoptosis,Immunology/Inflammation,MAPK,Proteases/Proteasome,Microbiology/Virology,GPCR/G Protein,NF-_b,MAPK,Neuroscience,Immunology/Inflammation,DNA Damage/DNA Repair,Cell Cycle/Checkpoint,Immunology/Inflammation,MAPK
Target:
NOS,TNF,Prostaglandin Receptor,JNK,HIV Protease,HIV Protease,Prostaglandin Receptor,NF-_B,p38 MAPK,COX,COX,DNA/RNA Synthesis,DNA/RNA Synthesis,IL Receptor,ERK
